# Pharmacodynamics of Omiganan (CLS001) in Patients With Atopic Dermatitis

> **NCT02456480** · PHASE2 · COMPLETED · sponsor: **Maruho Co., Ltd.** · enrollment: 37 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** CLS001
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT02456480
- **Lead sponsor:** Maruho Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2016-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02456480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02456480, "Pharmacodynamics of Omiganan (CLS001) in Patients With Atopic Dermatitis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02456480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*